Abstract Details
|
Natalie E. Parks, MD
(Dalhousie University)
PRESENTER |
Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Parks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
| Timothy J. Benstead, MD | No disclosure on file |
| Ian M. Grant, MD (Northwestern University) | No disclosure on file |
| No disclosure on file |